2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$8.20+$0.17 (+2.05%)
Price as of Aug 03, 2026 5:55 AM EDT- $518.1MMarket Cap
- 8.22%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$8.20+$0.17 (+2.05%)
ARVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.03 | ||
Change | -$0.27 (-3.25%) | ||
Open | $8.24 | ||
High | $8.24 | ||
Low | $7.89 | ||
Previous Close | $8.30 | ||
Volume | 687,895 | ||
30-Day Average Volume | 601,092 | ||
1-Week Change | 0.00% | ||
1-Month Change | -3.37% | ||
1-Year Change | 8.22% | ||
3-Year Change | -67.52% | ||
5-Year Change | -92.06% | ||
Fundamentals | |||
Shares Outstanding | 64.5M | ||
Total Assets | $647.5M | ||
Market Cap | $518.1M | ||
Enterprise Value | $431.3M | ||
Period: QTR TTM FY | |||
Revenue | $15.6M | ||
Net Income | -$57.6M | ||
Free Cash Flow | -$70.5M | ||
EBIT | -$57.5M | ||
EBITDA | -$56.8M | ||
Net Working Capital | $514.8M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue